摘要
应用ELISA法筛选巨细胞病毒(CMV)IgG效价≥1:30000的人血浆,合并后,按低温乙醇法精制出高效价CMV-IgG。经小规模人体应用观察无不良反应,且有71.4%(50/70)的CMV-IgM或CMV-IgA阳性人的血清转阴。
The human plasma containing high titer (≥1: 30000) cytomegalovirus(CMV)IgG was screened by ELISA and used for preparing high titer CMV-IgG by coldethanol fractionation method. Small-scale clinical trial revealed that average the patientstreated with CMV-IgG whose CMV-IgM or CMV-IgA were pos1tive with a serum averageconversion rate of 71.4%(50/70),and no adverse reaction was found.
出处
《中国生物制品学杂志》
CAS
CSCD
1995年第3期132-134,共3页
Chinese Journal of Biologicals